2658-6533Research Results in Biomedicine2658-653310.18413/2313-8955-2018-4-4-0-101602Medicine (miscellaneous)Nonpsychotic mental disorders in patients with benign hypersplasia of the prostate gland (clinic and therapy)Nonpsychotic mental disorders in patients with benign hypersplasia of the prostate gland (clinic and therapy)OchkolyasViktor I.OchkolyasViktor I.ochkolyas7@mail.ru20184400

Background: Benign prostatic hyperplasia (BPH) is the most common disease of the genitourinary system in elderly men. It hampers social functioning and reduces the quality of life. The aim of the study: To develop approaches to the provision of psychotherapeutic care of elderly patients with BPH based on the verification of the clinical picture of nonpsychotic psychiatric disorders. Materials and methods: 120 patients with BPH and nonpsychotic psychiatric disorders were examined: 60 patients treated conservatively and 60 patients at the stage of preparation for surgical intervention. The following research methods were used: clinical-psychopathological, psychometric and statistical (descriptive statistics, criterion c2 for conjugation tables 2x2, coefficient of rank correlation of Spearman). Results: It has been established that borderline mental disorders are observed in patients with BPH in 84.5%–89.5% of cases. The most representative were prolonged anxious and anxious-depressive reactions (18.3%–27.5%), apathic depressive and hypochondriacal (8.3%–15.0%), anxious-phobic reaction (16.7%) and anxiety-subdepressive and anxious reactions with conversion symptoms (13.3% and 11.7%). In patients with conservative therapy, the symptomatology was moderately expressed (17.5±0.09 points) and they assessed the quality of life as "unsatisfactory" (3.8±0.09 points), but those patients subject to surgical treatment were detected (t> 33.2 p<0.0001) to have more severe symptoms (31.1±0.4 points), and the quality of life was assessed (t>10.8 p<0.0001) as poor (5.2±0.1 points). Anxious, egocentric and ergopathic types of response to the disease were prevalent. Conclusion: Differentiated psychotherapy in the structure of complex treatment of patients with BPH with nonpsychotic psychiatric disorders should be built taking into account the basic approach to the therapy of somatic disease. This approach allows to reduce the degree of intensity of affective tension and fear of surgical intervention at the hospital stage, to reduce the main psychopathological symptoms and to teach skills of self-regulation.

Background: Benign prostatic hyperplasia (BPH) is the most common disease of the genitourinary system in elderly men. It hampers social functioning and reduces the quality of life. The aim of the study: To develop approaches to the provision of psychotherapeutic care of elderly patients with BPH based on the verification of the clinical picture of nonpsychotic psychiatric disorders. Materials and methods: 120 patients with BPH and nonpsychotic psychiatric disorders were examined: 60 patients treated conservatively and 60 patients at the stage of preparation for surgical intervention. The following research methods were used: clinical-psychopathological, psychometric and statistical (descriptive statistics, criterion c2 for conjugation tables 2x2, coefficient of rank correlation of Spearman). Results: It has been established that borderline mental disorders are observed in patients with BPH in 84.5%–89.5% of cases. The most representative were prolonged anxious and anxious-depressive reactions (18.3%–27.5%), apathic depressive and hypochondriacal (8.3%–15.0%), anxious-phobic reaction (16.7%) and anxiety-subdepressive and anxious reactions with conversion symptoms (13.3% and 11.7%). In patients with conservative therapy, the symptomatology was moderately expressed (17.5±0.09 points) and they assessed the quality of life as "unsatisfactory" (3.8±0.09 points), but those patients subject to surgical treatment were detected (t> 33.2 p<0.0001) to have more severe symptoms (31.1±0.4 points), and the quality of life was assessed (t>10.8 p<0.0001) as poor (5.2±0.1 points). Anxious, egocentric and ergopathic types of response to the disease were prevalent. Conclusion: Differentiated psychotherapy in the structure of complex treatment of patients with BPH with nonpsychotic psychiatric disorders should be built taking into account the basic approach to the therapy of somatic disease. This approach allows to reduce the degree of intensity of affective tension and fear of surgical intervention at the hospital stage, to reduce the main psychopathological symptoms and to teach skills of self-regulation.

benign prostatic hyperplasianonpsychotic mental disordersadaptation disorderspsychotherapybenign prostatic hyperplasianonpsychotic mental disordersadaptation disorderspsychotherapyСписок литературыVertkin АL, Rodyukova IS, Galkin IV, et al. [Not just the prostate: the problems of benign prostatic hyperplasia in the elderly]. Farmateka. 2009;9:50-55. Russian.Emberton M, Martorana G. BPH: Social impact and patient’s perspective. Eur. Urol. Suppl. 2006;5:991-996.Krivoborodov GG, Tur EI, Solovev VV. [The use of drugs Cernilton and Cernilton Forte in the treatment of chronic prostatitis and symptoms of the lower urinary tract due to benign prostatic hyperplasia]. Effektivnaya farmakoterapiya. 2013;26:48-53. Russian.Sivkov AB. [Drug therapy for benign prostatic hyperplasia]. In Lopatkin NА, editor. Dobrokachestvennaya giperplaziya predstatelnoj zhelezy [Benign prostatic hyperplasia]. Moscow: Vseros. o-vo urologov; 1997. P. 67-83. Russian.Dornas MC, Damião R, Carrerette FB. Tratamento contemporâneo não cirúrgico da hiperplasia prostática benigna // Revista do Hospital Universitário Pedro Ernesto, UERJ. 2010; 9(1): 48. Congresso do HUPE «Saúde do Homem». P. 35-39.Alyayev YuG, Grigoryan VA, Chinenov DV. [Diagnosis and treatment of benign prostatic hyperplasia]. Lechashhij vrach. 2007;4:70-73. Russian.Perepanova TS, Maksimov VА, Davydova EN, et al. [Setegis in the treatment of benign prostatic hyperplasia. Intermittent dosing regimen]. Russkij meditsinskij zhurnal. 2004;24:1458-1461. Russian.Barry MJ, Beckley S, Boyle P, et al. Importance of understanding the epidemiology and natural history of BPH. In: Cockett ATK, Aso Y, Chatelain C [et al.], editors. Proceedings of the international consultation on benign prostatic hyperplasia (BPH); 1991 June 26-27 Paris. Р. 13-21. Lim KB. Epidemiology of clinical benign prostatic hyperplasia. Asian. J. Urol. 2017;4(3):148-151.Danilin IE. [Borderline mental disorders in patients with tumors of the prostate] [dissertation]. Mosсow; 2003. Russian.Zakharushkina TS. [Mental disorders in benign prostatic hyperplasia at various stages of surgical treatment] [dissertation]. Mosсow; 2001. Russian.Zakharushkina TS, Аboyan IА, Pavlov SV. [Mental disorders in benign prostatic hyperplasia]. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2001;101(12):29-31. Russian.Zakharushkina TS, Аboyan IА, Pavlov SV. [Quality of life of patients with benign prostatic hyperplasia]. Sotsial'naya i klinicheskaya psikhiatriya. 2002;11(1):77-80. Russian.Marilov VV, Danilin IE. [Psychiatric disorders in patients with tumors of the prostate gland in a comparative aspect]. Sotsialnaya i klinicheskaya psikhiatriya. 2005;15(4):23-27. Russian.Koh JS, Ko HJ, Wang S-M, et al. The relationship between depression, anxiety, somatization, personality and symptoms of lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Psychiatry Investigation. 2015;12(2): 268-273.Matsukawa Y, Takai S, Funahashi Y, et al. Effects of withdrawing α1-blocker from combination therapy with α1-blocker and 5α-reductase inhibitor in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a prospective and comparative trial using urodynamics. J. Urol. 2017;198(4):905-912.Vasil'ev АO, Govorov АV, Kasyan GR, et al. [Benign prostatic hyperplasia: the possibility of using phosphodiesterase type 5 inhibitors]. Meditsinskij sovet. 2016;19:109-113. Russian.Pushkar DYu, Rasner PI, Skobelev PI. [Modern possibilities for screening prostate cancer in patients with BPH before and after surgery: a review]. Urologiya. 2001;6:48-54. Russian.Zelenski АI. [Sexual disorders in benign prostatic hyperplasia in young men]. Meditsinskaya psikhologiya. 2007;4:105-107. Russian.Yakhin KK, Nurtdinov АR, Sitdykova ME. [Features of the personality and mental state of patients with benign prostatic hyperplasia]. Meditsinskij vestnik Bashkortostana. 2017;12(4):21-24. Russian.